Medicinal Chemistry
Molecular and Precision Oncology
PhotomedicinePhotodynamic Cancer TherapyAntimicrobial PhototherapyPorphyrinsTetrapyrroles
Team/Members of the group:
Close Collaborators:
Biolitec Pharma, Alpheus Medical
Main Funders:
H2020, EIC, IRC, TU Munich
Active research programmes:
The Senge group develop novel anti-cancer photomedicines, pioneering strategies in low-collateral/high-effect emerging treatments. We bridge organic chemistry and cell biology with a translational focus, accelerating the availability of these treatment options to market.